---
$id: https://graph.org.ai/products/commodity/51202414
$type: Product
source: UNSPSC
code: "51202414"
title: "Ustekinumab"
class: "51202400"
classTitle: "Immunosupressant antibodies"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ustekinumab

**UNSPSC Code**: 51202414
**Class**: [Immunosupressant antibodies](Immunosupressant antibodies.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6482H10004N1712O2016S46, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FU77B4U5Z0, more generally known as ustekinumab. European Medicines Agency schedules ustekinumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27761. The term USTEKINUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 1, 2009, list 61. Most nations, for tariff and trade purposes, schedule Ustekinumab under HS 30021020 and SITC 54163. SMILES:. As of Q4 2014, USTEKINUMAB remains US FDA's Preferred Term for this commodity. . Ustekinumab bears US NLM identifiers UMLS ID C1608841 and NCI Concept Code C84237.

